Cancer survival - melanoma

Back

Please note that these indicators are not currently up to date and will be replaced shortly with dashboards. In the meantime the most currently available data is available at https://www.data.act.gov.au or contact healthinfo@act.gov.au

Commentary

Five-year relative survival for melanoma has not changed significantly over time, from 91.4% in the period 1988–1997 to 90.3% for the period 2008–2017. While there were no significant differences in survival for males and females, people aged 0–64 years had better survival (95%) than those aged 65 and over (84%). Despite the 90% 5-year relative survival, the disease remains a significant health problem for the ACT community. The treatment of advanced stage melanoma has recently improved dramatically and may further improve relative survival rates in years to come.^1-8

Australian Institute of Health and Welfare (AIHW). Cancer in Australia 2021. Canberra: AIHW; 2021 [cited 2022 Apr 6].

2. ACT Cancer Registry. Canberra: ACT Cancer Registry; 2022

3. Australian Bureau of Statistics (ABS). Life Tables, States, Territories and Australia, 2015-2017. Canberra: ABS; 2019 [cited 2022 Apr 6].

4. ABS. Life Tables, States, Territories and Australia, 2014-2016. Canberra: ABS; 2018 [cited 2022 Apr 6].

5. ABS. Life Tables, States, Territories and Australia, 2013-2015. Canberra: ABS; 2017 [cited 2022 Apr 6].

6. ABS. Life Tables, States, Territories and Australia, 2012-2014. Canberra: ABS; 2016 [cited 2022 Apr 6].

7. ABS. Life Tables, States, Territories and Australia, 2011-2013. Canberra: ABS; 2015 [cited 2022 Apr 6].

8. Cancer Council Australia Melanoma Guidelines Working Party. Clinical practice guidelines for the diagnosis and management of melanoma. Sydney: Melanoma Institute Australia, 2020 [cited 2022 Apr 6].